Cargando…
Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis
AIMS: Outcomes of current operative treatments for arthrofibrosis after total knee arthroplasty (TKA) are not consistently positive or predictable. Pharmacological in vivo studies have focused mostly on prevention of arthrofibrosis. This study used a rabbit model to evaluate intra-articular (IA) eff...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The British Editorial Society of Bone & Joint Surgery
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801169/ https://www.ncbi.nlm.nih.gov/pubmed/35084209 http://dx.doi.org/10.1302/2046-3758.111.BJR-2021-0546.R1 |
_version_ | 1784642395060568064 |
---|---|
author | Trousdale, William H. Limberg, Afton K. Reina, Nicolas Salib, Christopher G. Thaler, Roman Dudakovic, Amel Berry, Daniel J. Morrey, Mark E. Sanchez-Sotelo, Joaquin van Wijnen, Andre Abdel, Matthew P. |
author_facet | Trousdale, William H. Limberg, Afton K. Reina, Nicolas Salib, Christopher G. Thaler, Roman Dudakovic, Amel Berry, Daniel J. Morrey, Mark E. Sanchez-Sotelo, Joaquin van Wijnen, Andre Abdel, Matthew P. |
author_sort | Trousdale, William H. |
collection | PubMed |
description | AIMS: Outcomes of current operative treatments for arthrofibrosis after total knee arthroplasty (TKA) are not consistently positive or predictable. Pharmacological in vivo studies have focused mostly on prevention of arthrofibrosis. This study used a rabbit model to evaluate intra-articular (IA) effects of celecoxib in treating contracted knees alone, or in combination with capsular release. METHODS: A total of 24 rabbits underwent contracture-forming surgery with knee immobilization followed by remobilization surgery at eight weeks. At remobilization, one cohort underwent capsular release (n = 12), while the other cohort did not (n = 12). Both groups were divided into two subcohorts (n = 6 each) – one receiving IA injections of celecoxib, and the other receiving injections of vehicle solution (injections every day for two weeks after remobilization). Passive extension angle (PEA) was assessed in live rabbits at 10, 16, and 24 weeks, and disarticulated limbs were analyzed for capsular stiffness at 24 weeks. RESULTS: IA celecoxib resulted in greater mean PEA at ten weeks (69.6° (SD 4.6) vs 45.2° (SD 9.6), p = 0.004), 16 weeks (109.8° (SD 24.2) vs 60.9° (SD10.9), p = 0.004), and 24 weeks (101.0° (SD 8.0) vs 66.3° (SD 5.8), p = 0.004). Capsular stiffness was significantly reduced with IA celecoxib (2.72 Newton per cm (N·cm)/° (SD 1.04), p = 0.008), capsular release (2.41 N·cm/° (SD 0.80), p = 0.008), and capsular release combined with IA celecoxib (3.56 N·cm/° (SD 0.99), p = 0.018) relative to IA vehicle (6.09 N·cm/° (SD 1.64)). CONCLUSION: IA injections of a celecoxib led to significant improvements in passive extension angles, with reduced capsular stiffness, when administered to rabbit knees with established experimental contracture. Celecoxib was superior to surgical release, and the combination of celecoxib and a surgical release did not provide any additional value. Cite this article: Bone Joint Res 2022;11(1):32–39. |
format | Online Article Text |
id | pubmed-8801169 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | The British Editorial Society of Bone & Joint Surgery |
record_format | MEDLINE/PubMed |
spelling | pubmed-88011692022-02-22 Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis Trousdale, William H. Limberg, Afton K. Reina, Nicolas Salib, Christopher G. Thaler, Roman Dudakovic, Amel Berry, Daniel J. Morrey, Mark E. Sanchez-Sotelo, Joaquin van Wijnen, Andre Abdel, Matthew P. Bone Joint Res Knee AIMS: Outcomes of current operative treatments for arthrofibrosis after total knee arthroplasty (TKA) are not consistently positive or predictable. Pharmacological in vivo studies have focused mostly on prevention of arthrofibrosis. This study used a rabbit model to evaluate intra-articular (IA) effects of celecoxib in treating contracted knees alone, or in combination with capsular release. METHODS: A total of 24 rabbits underwent contracture-forming surgery with knee immobilization followed by remobilization surgery at eight weeks. At remobilization, one cohort underwent capsular release (n = 12), while the other cohort did not (n = 12). Both groups were divided into two subcohorts (n = 6 each) – one receiving IA injections of celecoxib, and the other receiving injections of vehicle solution (injections every day for two weeks after remobilization). Passive extension angle (PEA) was assessed in live rabbits at 10, 16, and 24 weeks, and disarticulated limbs were analyzed for capsular stiffness at 24 weeks. RESULTS: IA celecoxib resulted in greater mean PEA at ten weeks (69.6° (SD 4.6) vs 45.2° (SD 9.6), p = 0.004), 16 weeks (109.8° (SD 24.2) vs 60.9° (SD10.9), p = 0.004), and 24 weeks (101.0° (SD 8.0) vs 66.3° (SD 5.8), p = 0.004). Capsular stiffness was significantly reduced with IA celecoxib (2.72 Newton per cm (N·cm)/° (SD 1.04), p = 0.008), capsular release (2.41 N·cm/° (SD 0.80), p = 0.008), and capsular release combined with IA celecoxib (3.56 N·cm/° (SD 0.99), p = 0.018) relative to IA vehicle (6.09 N·cm/° (SD 1.64)). CONCLUSION: IA injections of a celecoxib led to significant improvements in passive extension angles, with reduced capsular stiffness, when administered to rabbit knees with established experimental contracture. Celecoxib was superior to surgical release, and the combination of celecoxib and a surgical release did not provide any additional value. Cite this article: Bone Joint Res 2022;11(1):32–39. The British Editorial Society of Bone & Joint Surgery 2022-01-27 /pmc/articles/PMC8801169/ /pubmed/35084209 http://dx.doi.org/10.1302/2046-3758.111.BJR-2021-0546.R1 Text en © 2022 Author(s) et al. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial No Derivatives (CC BY-NC-ND 4.0) licence, which permits the copying and redistribution of the work only, and provided the original author and source are credited. See https://creativecommons.org/licenses/by-nc-nd/4.0/ |
spellingShingle | Knee Trousdale, William H. Limberg, Afton K. Reina, Nicolas Salib, Christopher G. Thaler, Roman Dudakovic, Amel Berry, Daniel J. Morrey, Mark E. Sanchez-Sotelo, Joaquin van Wijnen, Andre Abdel, Matthew P. Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis |
title | Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis |
title_full | Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis |
title_fullStr | Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis |
title_full_unstemmed | Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis |
title_short | Intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis |
title_sort | intra-articular celecoxib improves knee extension regardless of surgical release in a rabbit model of arthrofibrosis |
topic | Knee |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8801169/ https://www.ncbi.nlm.nih.gov/pubmed/35084209 http://dx.doi.org/10.1302/2046-3758.111.BJR-2021-0546.R1 |
work_keys_str_mv | AT trousdalewilliamh intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT limbergaftonk intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT reinanicolas intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT salibchristopherg intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT thalerroman intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT dudakovicamel intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT berrydanielj intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT morreymarke intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT sanchezsotelojoaquin intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT vanwijnenandre intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis AT abdelmatthewp intraarticularcelecoxibimproveskneeextensionregardlessofsurgicalreleaseinarabbitmodelofarthrofibrosis |